APA (7th ed.) Citation

Y, G., Z, L., L, X., J, L., S, Q., C, S., . . . Y, S. (2026). Efficacy and safety of toripalimab in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): A phase 1b/2 study. Signal transduction and targeted therapy, 11(1), . https://doi.org/10.1038/s41392-026-02707-3

Chicago Style (17th ed.) Citation

Y, Guo, et al. "Efficacy and Safety of Toripalimab in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC): A Phase 1b/2 Study." Signal Transduction and Targeted Therapy 11, no. 1 (2026). https://doi.org/10.1038/s41392-026-02707-3.

MLA (9th ed.) Citation

Y, Guo, et al. "Efficacy and Safety of Toripalimab in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC): A Phase 1b/2 Study." Signal Transduction and Targeted Therapy, vol. 11, no. 1, 2026, https://doi.org/10.1038/s41392-026-02707-3.